| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |